TVAX Biomedical Announces Receipt of $2 Million FDA Orphan Products Grant for Glioblastoma Study
October 18, 2022 10:07 ET
|
TVAX Biomedical
OLATHE, Kan., Oct. 18, 2022 (GLOBE NEWSWIRE) -- TVAX Biomedical (TVAX) is a cancer immunotherapy company that is moving into its pivotal glioblastoma study for FDA regulatory approval. In September...
Harpoon Therapeutics Appoints Luke Walker, M.D., as Chief Medical Officer
October 04, 2022 07:30 ET
|
Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today announced the...
mRNA Cancer Therapies Patent Landscape 2022: Featuring BioNTech, Moderna, Novartis, Sanofi & Others
October 04, 2022 04:03 ET
|
Research and Markets
Dublin, Oct. 04, 2022 (GLOBE NEWSWIRE) -- The "mRNA Cancer Therapies Patent Landscape 2022" report has been added to ResearchAndMarkets.com's offering. For nearly three decades, extensive efforts...
Harpoon Therapeutics Appoints Lauren Silvernail to Board of Directors
September 19, 2022 16:05 ET
|
Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today announced...
Global Engineered T Cells Market Report 2022-2027: Increasing Demand for Innovative Biopharmaceutical Therapies & Recent Advances in CAR-T Cell Engineering Propelling Sector
August 11, 2022 08:48 ET
|
Research and Markets
Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "Global Engineered T Cells Market (2022-2027) by Type, Application, End User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff...
Global CAR-T Therapy Market Report 2022-2026 & 2031: Focus on Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA
August 03, 2022 06:03 ET
|
Research and Markets
Dublin, Aug. 03, 2022 (GLOBE NEWSWIRE) -- The "CAR-T Therapy Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The global CAR-T therapy market is expected to...
Global T-Cell Immunotherapy Market Report to 2027 - Featuring Atara Biotherapeutics, Autolus and bluebird bio Among Others
July 21, 2022 07:18 ET
|
Research and Markets
Dublin, July 21, 2022 (GLOBE NEWSWIRE) -- The "T-Cell Immunotherapy Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global...
Harpoon Therapeutics Expands Leadership Team
July 06, 2022 07:30 ET
|
Harpoon Therapeutics
Appointments named for two key executive leadership positions in human resources and translational medicine SOUTH SAN FRANCISCO, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc....
Global CAR T Cell Therapy Market Research 2022: Opportunity & Clinical Pipeline Insights to 2028 - Insight On More Than 600 CAR T Cell Therapies In Clinical Trials
June 16, 2022 04:33 ET
|
Research and Markets
Dublin, June 16, 2022 (GLOBE NEWSWIRE) -- The "Global CAR T Cell Therapy Market Opportunity & Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. ...
Outlook on the KRAS Inhibitors Global Market to 2028 - Key Drivers and Challenges
April 27, 2022 05:28 ET
|
Research and Markets
Dublin, April 27, 2022 (GLOBE NEWSWIRE) -- The "Global KRAS Inhibitors Market & Clinical Trials Forecast 2028" report has been added to ResearchAndMarkets.com's offering. The advancement in...